about
Microbiota-based treatments in alcoholic liver diseaseGut microbiota in alcoholic liver disease: pathogenetic role and therapeutic perspectivesGastrointestinal effects of low-digestible carbohydratesPrebiotic effect of fruit and vegetable shots containing Jerusalem artichoke inulin: a human intervention study.Comparison of Yacon (Smallanthus sonchifolius) Tuber with Commercialized Fructo-oligosaccharides (FOS) in Terms of Physiology, Fermentation Products and Intestinal Microbial Communities in RatsTeleost microbiomes: the state of the art in their characterization, manipulation and importance in aquaculture and fisheriesCholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.Effects of extruded whole maize, polydextrose and cellulose as sources of fibre on calcium bioavailability and metabolic parameters of growing Wistar rats.Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial.Specific response of a novel and abundant Lactobacillus amylovorus-like phylotype to dietary prebiotics in the guts of weaning pigletsMaternal Supplementation with Oligofructose (10%) during Pregnancy and Lactation Leads to Increased Pro-Inflammatory Status of the 21-D-Old Offspring.Characterization of the Intestinal Lactobacilli Community following Galactooligosaccharides and Polydextrose Supplementation in the Neonatal PigletClinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's diseaseProbiotics and the management of inflammatory bowel disease.Promises and problems of functional foods.Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.Non-digestible oligosaccharides with prebiotic properties.Polydextrose Enhances Calcium Absorption and Bone Retention in Ovariectomized Rats.Low-molecular-weight fucoidan and high-stability fucoxanthin from brown seaweed exert prebiotics and anti-inflammatory activities in Caco-2 cells.Efficacy of partially hydrolyzed guar gum (PHGG) supplemented modified oral rehydration solution in the treatment of severely malnourished children with watery diarrhoea: a randomised double-blind controlled trial.Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium studyOligofructose supplementation during pregnancy and lactation impairs offspring development and alters the intestinal properties of 21-d-old pups.Infant nutrition and allergy.Microbiota and dietary interactions: an update to the hygiene hypothesis?Dietary roles of non-starch polysaccharides in human nutrition: a review.Prebiotics: application in bakery and pasta products.Microbial enzymatic production and applications of short-chain fructooligosaccharides and inulooligosaccharides: recent advances and current perspectives.Potential of fructooligosaccharide prebiotics in alternative and nonconventional poultry production systems.Fructooligosaccharide raftilose reduces the mycophenolate mofetil-induced complications: Hematological and biochemical alterations.Short Chain and Polyunsaturated Fatty Acids in Host Gut Health and Foodborne Bacterial Pathogen Inhibition.Recovery and purification of oligosaccharides from copra meal by recombinant endo-β-mannanase and deciphering molecular mechanism involved and its role as potent therapeutic agent.Cellobiose Prevents the Development of Dextran Sulfate Sodium (DSS)-Induced Experimental ColitisPrebiotics as functional food ingredients preventing diet-related diseases.Effects of Probiotics, Prebiotics, and Synbiotics on Human Health.Butyrate stimulates IL-32alpha expression in human intestinal epithelial cell lines.Anticoccidial effect of mananoligosacharide against experimentally induced coccidiosis in broiler.Development of a complex amino acid supplement, Fatigue Reviva™, for oral ingestion: initial evaluations of product concept and impact on symptoms of sub-health in a group of malesCarbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".Ability of a high-total antioxidant capacity diet to increase stool weight and bowel antioxidant status in human subjects.A human volunteer study to assess the impact of confectionery sweeteners on the gut microbiota composition.
P2860
Q26740192-D79C5B91-B982-44C2-940B-12CF0674EC8EQ26864127-002127A2-D033-4764-9EA5-41E08FCBAF21Q28235996-F9AB9CF5-C4EE-444C-8232-36A069C8A403Q33445319-36D225EF-3114-4256-8D8B-F95FD39C386CQ33666212-241B77E6-7D7C-4215-85B1-A4BFE48005CFQ33693827-F6494396-B94C-4121-84BC-95B77655BC70Q33998828-5EE70397-076B-4B57-96E5-0AFACED6E85DQ35104203-428A396A-A4A5-4C8B-BC0C-467C224E46E4Q35219108-F58DB72E-BB3E-4D29-B485-6785A2165445Q35663420-5AE8AA6F-5D6F-4DA8-9677-A07C99A171C8Q35683224-40FEBA69-AC72-4456-9F01-A7FB8435C525Q35746500-A440DBF2-88C5-4A78-8C51-28DB2659C84AQ35760252-06858ACC-36BB-4D9A-A5C3-B6EB1BAF0B8CQ35854517-F0FD6893-EB91-4C0D-ADB8-E1B797101B6AQ35947061-ACC3F6C1-77F3-4C7B-B10E-4013CF997FC5Q36014389-A21B829E-9095-4648-9D07-1C1E13525A24Q36545386-D425BB84-5CD4-4D23-A98B-031CF3360D4AQ36556778-EF8FCF61-3C44-4448-9558-EF6C39DF1B4EQ37151738-8F87FED8-4E4C-4536-9C0B-DB0A8940219BQ37261469-51F791B8-0115-4522-BBE7-56C7581D5715Q37263314-559EBA58-5788-4CE1-B39C-D7BC8872BE9BQ37590784-D7BE1B34-4960-4914-A2D2-9843F3ED3D2CQ37924340-79BE82CA-DDE6-4315-BC62-DE4518511E29Q37976874-B41B3A45-C23B-46F2-8FFD-F483CFD25D90Q38022684-B2DF2812-393B-490D-B1F8-CCBB8580FA33Q38162967-B3412D42-1D46-4B1B-8ADA-AF9809CFB9A3Q38209077-A5185C05-2583-4644-A745-E30A159FF5E3Q38365368-9856C6EC-EABD-4119-BE9A-47E3E6A28C99Q38655997-CBFF65D4-4335-4A98-A14D-140FB5B0A9F9Q38903226-42FA3F9E-4FE6-422E-AB9E-5BE41CAA895EQ38952944-A496BC63-A689-4C66-ADEE-34E8CBCA06F9Q39366025-12C093BF-87ED-4A06-9688-C3C0FA85F519Q39933158-ABE39A71-8FD9-4D9B-B018-F4B04835B182Q40044003-B9524498-92A0-4FA1-B843-3815EBB8B31DQ40674604-15406DB6-98B6-48D6-BBDB-518AF1E281D2Q40718558-6A8F3F97-E3DF-4DDC-B31A-CD24A4469C48Q41980413-C0CEB0FD-7F75-4C7E-A06C-DC261C85777BQ42589189-43283BD2-5C65-4FDD-8E72-AAEC644012FAQ43005153-DF5ABDD0-646C-497B-9978-7FD5132DDFA2Q43108368-A0BCE7D9-4EB8-4C7C-9FCA-AC6D5248149D
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Gastrointestinal effects of prebiotics.
@ast
Gastrointestinal effects of prebiotics.
@en
Gastrointestinal effects of prebiotics.
@nl
type
label
Gastrointestinal effects of prebiotics.
@ast
Gastrointestinal effects of prebiotics.
@en
Gastrointestinal effects of prebiotics.
@nl
prefLabel
Gastrointestinal effects of prebiotics.
@ast
Gastrointestinal effects of prebiotics.
@en
Gastrointestinal effects of prebiotics.
@nl
P2860
P356
P1476
Gastrointestinal effects of prebiotics.
@en
P2093
Cummings JH
Macfarlane GT
P2860
P304
P356
10.1079/BJN/2002530
P478
87 Suppl 2
P577
2002-05-01T00:00:00Z